• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟喹诺酮类药物的安全性。

Safety of fluoroquinolones.

机构信息

José Barberán, Hospital Universitario HM Montepríncipe, Facultad HM Hospitales de Ciencias de la Salud, Universidad Camilo José Cela, Madrid, Spain.

出版信息

Rev Esp Quimioter. 2024 Apr;37(2):127-133. doi: 10.37201/req/143.2023. Epub 2023 Dec 22.

DOI:10.37201/req/143.2023
PMID:38140798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10945095/
Abstract

Fluoroquinolones (FQs) are one of the most commonly prescribed classes of antibiotics. Although they were initially well tolerated in randomized clinical trials, subsequent epidemiological studies have reported an increased risk of threatening, severe, long-lasting, disabling and irreversible adverse effects (AEs), related to neurotoxicity and collagen degradation, such as tendonitis, Achilles tendon rupture, aortic aneurysm, and retinal detachment. This article reviews the main potentially threatening AEs, the alarms issued by regulatory agencies and therapeutic alternatives.

摘要

氟喹诺酮类药物(FQs)是最常用的抗生素类别之一。尽管它们在随机临床试验中最初被很好地耐受,但随后的流行病学研究报告了与神经毒性和胶原降解相关的威胁性、严重、持久、致残和不可逆转的不良事件(AE)的风险增加,如肌腱炎、跟腱断裂、主动脉瘤和视网膜脱离。本文综述了主要的潜在威胁性 AE、监管机构发出的警报以及治疗替代方案。

相似文献

1
Safety of fluoroquinolones.氟喹诺酮类药物的安全性。
Rev Esp Quimioter. 2024 Apr;37(2):127-133. doi: 10.37201/req/143.2023. Epub 2023 Dec 22.
2
Fluoroquinolones and Aortic Diseases: Is There a Connection.氟喹诺酮类药物与主动脉疾病:存在关联吗?
Aorta (Stamford). 2019 Apr;7(2):35-41. doi: 10.1055/s-0039-1693468. Epub 2019 Sep 17.
3
Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection.氟喹诺酮类药物——主动脉夹层和动脉瘤风险增加的现状。
BMC Cardiovasc Disord. 2021 Sep 28;21(1):470. doi: 10.1186/s12872-021-02258-1.
4
Fluoroquinolones and tendinopathy: a guide for athletes and sports clinicians and a systematic review of the literature.氟喹诺酮类药物与肌腱病:运动员及运动医学临床医生指南及文献系统综述
J Athl Train. 2014 May-Jun;49(3):422-7. doi: 10.4085/1062-6050-49.2.09. Epub 2014 Apr 24.
5
Fluoroquinolone-associated tendinopathy.氟喹诺酮相关性肌腱病
Chang Gung Med J. 2011 Sep-Oct;34(5):461-7.
6
Tendon Injury and Fluoroquinolone Use: A Systematic Review.肌腱损伤与氟喹诺酮类药物的使用:一项系统评价
Drug Saf. 2013 Sep;36(9):709-21. doi: 10.1007/s40264-013-0089-8.
7
Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study.氟喹诺酮类药物与胶原蛋白相关的严重不良事件:一项纵向队列研究。
BMJ Open. 2015 Nov 18;5(11):e010077. doi: 10.1136/bmjopen-2015-010077.
8
Tendinopathy resulting from the use of fluoroquinolones: managing risks.使用氟喹诺酮类药物导致的肌腱病:风险管理
JAAPA. 2010 Dec;23(12):18-21, 54. doi: 10.1097/01720610-201012000-00005.
9
A preventable, life-altering case of fluoroquinolone-associated tendonitis.一起可预防的、改变人生的氟喹诺酮类药物相关肌腱炎案例。
JAAPA. 2022 Nov 1;35(11):33-36. doi: 10.1097/01.JAA.0000873776.37967.9b.
10
Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?氟喹诺酮类药物相关性肌腱病:左氧氟沙星的风险最大吗?
Pharmacotherapy. 2016 Jun;36(6):679-93. doi: 10.1002/phar.1761. Epub 2016 Jun 11.

引用本文的文献

1
Repurposing fluoroquinolones as cancer chemosensitizers: a way to overcome cancer therapeutic bottleneck.将氟喹诺酮类药物重新用作癌症化疗增敏剂:一种克服癌症治疗瓶颈的方法。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 11. doi: 10.1007/s00210-025-04508-x.
2
(Fluoro)quinolone prescriptions for upper respiratory tract infections in the German outpatient sector: a health insurance claims analysis.德国门诊部门治疗上呼吸道感染的(氟)喹诺酮类药物处方:一项医疗保险理赔分析
GMS Infect Dis. 2025 May 27;13:Doc01. doi: 10.3205/id000091. eCollection 2025.
3
Preliminary Analysis of Drug-Induced Ototoxicity in South Korea: Trends From a National Sample Dataset.韩国药物性耳毒性的初步分析:来自全国样本数据集的趋势
J Audiol Otol. 2025 Apr;29(2):110-116. doi: 10.7874/jao.2024.00493. Epub 2025 Apr 18.
4
Anti-inflammatory effects of moxifloxacin and levofloxacin on cadmium-activated human astrocytes: Inhibition of proinflammatory cytokine release, TLR4/STAT3, and ERK/NF-κB signaling pathway.莫西沙星和左氧氟沙星对镉激活的人星形胶质细胞的抗炎作用:抑制促炎细胞因子释放、TLR4/STAT3和ERK/NF-κB信号通路。
PLoS One. 2025 Jan 14;20(1):e0317281. doi: 10.1371/journal.pone.0317281. eCollection 2025.

本文引用的文献

1
Depressive and Other Adverse CNS Effects of Fluoroquinolones.氟喹诺酮类药物的抑郁及其他中枢神经系统不良反应
Pharmaceuticals (Basel). 2023 Aug 4;16(8):1105. doi: 10.3390/ph16081105.
2
Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?氟喹诺酮类抗菌药物的副作用概述:新药与旧药对比,安全性方面是否有所进步?
Pharmaceutics. 2023 Mar 1;15(3):804. doi: 10.3390/pharmaceutics15030804.
3
Impact of European Union Label Changes for Fluoroquinolone-Containing Medicinal Products for Systemic and Inhalation Use: Post-Referral Prescribing Trends.欧盟标签变更对全身用和吸入用含氟喹诺酮类药物的影响:上市后处方趋势。
Drug Saf. 2023 Apr;46(4):405-416. doi: 10.1007/s40264-023-01286-4. Epub 2023 Mar 28.
4
Short-Term Exposure to Ciprofloxacin Reduces Proteoglycan Loss in Tendon Explants.短期接触环丙沙星可减少肌腱外植体中蛋白聚糖的丢失。
Genes (Basel). 2022 Nov 25;13(12):2210. doi: 10.3390/genes13122210.
5
Fluoroquinolone-associated suspected tendonitis and tendon rupture: A pharmacovigilance analysis from 2016 to 2021 based on the FAERS database.氟喹诺酮类药物相关的疑似肌腱炎和肌腱断裂:基于FAERS数据库的2016年至2021年药物警戒分析。
Front Pharmacol. 2022 Sep 6;13:990241. doi: 10.3389/fphar.2022.990241. eCollection 2022.
6
Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part II.重症监护病房患者抗菌药物的组织穿透性:系统评价 - 第二部分
Antibiotics (Basel). 2022 Sep 3;11(9):1193. doi: 10.3390/antibiotics11091193.
7
Do fluoroquinolones increase aortic aneurysm or dissection incidence and mortality? A systematic review and meta-analysis.氟喹诺酮类药物会增加主动脉瘤或主动脉夹层的发生率及死亡率吗?一项系统评价与荟萃分析。
Front Cardiovasc Med. 2022 Aug 9;9:949538. doi: 10.3389/fcvm.2022.949538. eCollection 2022.
8
Positive Association Between Fluoroquinolone Exposure and Tendon Disorders: A Nationwide Population-Based Cohort Study in Taiwan.氟喹诺酮类药物暴露与肌腱疾病之间的正相关关系:台湾一项基于全国人口的队列研究。
Front Pharmacol. 2022 Mar 21;13:814333. doi: 10.3389/fphar.2022.814333. eCollection 2022.
9
Systemic quinolones and risk of retinal detachment III: a nested case-control study using a US electronic health records database.全身用喹诺酮类药物与视网膜脱离风险 III:一项使用美国电子健康记录数据库的巢式病例对照研究。
Eur J Clin Pharmacol. 2022 Jun;78(6):1019-1028. doi: 10.1007/s00228-021-03260-4. Epub 2022 Mar 15.
10
Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: a nested case-control study.韩国使用氟喹诺酮类药物导致主动脉瘤和主动脉夹层的风险:一项巢式病例对照研究。
BMC Cardiovasc Disord. 2022 Feb 13;22(1):44. doi: 10.1186/s12872-022-02488-x.